Brief: Tela Bio Reports Third Quarter 2022 Financial Results
09/11/2022 21:07
TELA Bio Inc TELA.O :
* TELA BIO REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS
* TELA BIO INC Q3 REVENUE ROSE 46 PERCENT TO $11.2 MILLION
* TELA BIO INC- CONTINUE TO EXPECT FULL YEAR 2022 REVENUE TO
RANGE
FROM $42 MILLION TO $45 MILLION
* TELA BIO INC - QTRLY NET LOSS PER COMMON SHARE, BASIC AND
DILUTED $0.64
Source text for Eikon: ID:nGNXnFZkl
Further company coverage: TELA.O
Recent news on TELA Bio
See all newsBrief: Tela Bio - Receives FDA 510(K) Clearance For Liora Monofilament Scaffold For Soft Tissue Reinforcement
Tela Bio Inc Reports Results For The Quarter Ended June 30: Earnings Summary
TELA Bio Q2 revenue falls on lower OviTex PRS volumes, withdraws outlook
Brief: TELA Bio Q2 Revenue USD 19.291 Million Vs. IBES Estimate USD 20 Million
Tela Bio Inc Expected To Post A Loss Of 18 Cents A Share: Earnings Preview